Search Results - Arndt Vogel
- Showing 1 - 20 results of 125
- Go to Next Page
-
1
Autoimmune Hepatitis, From Mechanisms to Therapy by Michael P. Manns, Arndt Vogel
Published 2006Revisão -
2
Epidemiology and Risk Factors of Cholangiocarcinoma by Martha M. Kirstein, Arndt Vogel
Published 2016Artigo -
3
FGFR inhibitors in cholangiocarcinoma: what’s now and what’s next? by Anna Saborowski, Ulrich Lehmann, Arndt Vogel
Published 2020Revisão -
4
-
5
FGFR2 Inhibition in Cholangiocarcinoma by Arndt Vogel, Oreste Segatto, Albrecht Stenzinger, Anna Saborowski
Published 2022Revisão -
6
-
7
The Diagnosis and Treatment of Cholangiocarcinoma by Arndt Vogel, Henning Wege, Karel Caca, Björn Nashan, Ulf P. Neumann
Published 2014Revisão -
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines by Arndt Vogel, Erika Martinelli, Arndt Vogel, Andrés Cervantes, Ian Chau, Bruno Daniele, Josep M. Llovet, Tim Meyer, Jean‐Charles Nault, Ulf P. Neumann, Jens Ricke, Bruno Sangro, Peter Schirmacher, Chris Verslype, Francis Zech, Dirk Arnold, Erika Martinelli
Published 2021Artigo -
20
Search Tools:
Related Subjects
Medicine
Internal medicine
Oncology
Hepatocellular carcinoma
Cancer
Gastroenterology
Biology
Chemotherapy
Immunotherapy
Cancer research
Genetics
Pathology
Adverse effect
Gene
Sorafenib
Bevacizumab
Disease
Cirrhosis
Immunology
Biochemistry
Nivolumab
Surgery
Atezolizumab
Clinical trial
Cohort
Cell biology
Confidence interval
Environmental health
Population
Pembrolizumab